We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immune Pharmaceuticals Licenses a Novel Bispecific Antibody Technology

News   Dec 29, 2015

 
Immune Pharmaceuticals Licenses a Novel Bispecific Antibody Technology
 
 
 

RELATED ARTICLES

3-in-1 Vaccine Against Traveller’s Diarrhea

News

Conjugate vaccines could be a platform for a multi-pathogen, multi-serotype vaccine against the three major causes of diarrheal disease worldwide.

READ MORE

Lassa Fever Vaccine Shows Promise and Reveals New Test for Immunity

News

A new Lassa fever and rabies vaccine shows lasting immunity and suggests a new way to test for protection.

READ MORE

Latent Reservoir of HIV Targeted with Two-Pronged Approach

News

Eliminating the latent viral reservoir is the critical barrier for the development of a cure for HIV-1 infection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE